Mometamax Ultra RSSAuthorisedThis medicine is authorised for use in the European Uniongentamicin / posaconazole / mometasone furoateMedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on Mometamax UltraOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.Product detailsName of medicine Mometamax Ultra Active substancegentamicinMometasone furoateposaconazoleInternational non-proprietary name (INN) or common namegentamicinposaconazolemometasone furoatePharmacotherapeutic groupOtologicalsCorticosteroidsAntiinfectivesAuthorisation detailsEMA product number EMEA/V/C/004987 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Mometamax UltraAdoptedReference Number: EMA/CVMP/793345/2022 English (EN) (136.12 KB - PDF)First published: 07/10/2022ViewNews on Mometamax UltraMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 202207/10/2022This page was last updated on 08/02/2024Share this pageHow useful do you find this page?12345